Psycho educational Therapy and Positive and Negative Symptoms of patients with Chronic Schizophrenia Disorder

Clinical Trial of the Effectiveness of Psycho educational Therapy on the Positive and Negative Symptoms of people with Chronic Schizophrenia Disorder

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20150427021965N12

Enrollment

Registered

2019-08-26

Start date

2019-07-23

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia Disorder. Schizophrenia

Interventions

Intervention 1: Intervention group: The intervention group will be treated as common with psychotherapy based on psychological training. The training will be run by a psychiatrist assistant who is fam

Eligibility

Sex/Gender

All

Age

18 Years to 35 Years

Inclusion criteria

Inclusion criteria: All patients referred to the clinic of the Shafa Hospital who has a diagnosis of chronic schizophrenia based on DSM-5 criteria and in controlled conditions. Members must have at least elementary education. Patients aged 18-35 years old Have the desire to enter the study.

Exclusion criteria

Exclusion criteria: Having other psychiatric disorders Having physically debilitating disease

Design outcomes

Primary

Measure	Time frame
Positive symptoms of schizophrenia disorder. Timepoint: Patients will be evaluated before the intervention, after the end of the intervention session and one month after the intervention. Method of measurement: Patients will be evaluated by Positive and Negative Syndrome Scale (PNSS).;Negative symptoms of schizophrenia disorder. Timepoint: Patients will be evaluated before the intervention, after the end of the intervention session and one month after the intervention. Method of measurement: Patients will be evaluated by Positive and Negative Syndrome Scale (PNSS).;Depression symptoms. Timepoint: Patients will be evaluated before the intervention, after the end of the intervention session and one month after the intervention. Method of measurement: Patients will be evaluated by Beck Depression Scale.;Symptoms of Anxiety. Timepoint: Patients will be evaluated before the intervention, after the end of the intervention session and one month after the intervention. Method of measurement: Patients will be evaluated by Beck Anxiety Scale.;Quality of Life. Timepoint: Patients will be evaluated before the intervention, after the end of the intervention session and one month after the intervention. Method of measurement: Patients will be evaluated by SF36.	—

Measure

Time frame

Positive symptoms of schizophrenia disorder. Timepoint: Patients will be evaluated before the intervention, after the end of the intervention session and one month after the intervention. Method of measurement: Patients will be evaluated by Positive and Negative Syndrome Scale (PNSS).;Negative symptoms of schizophrenia disorder. Timepoint: Patients will be evaluated before the intervention, after the end of the intervention session and one month after the intervention. Method of measurement: Patients will be evaluated by Positive and Negative Syndrome Scale (PNSS).;Depression symptoms. Timepoint: Patients will be evaluated before the intervention, after the end of the intervention session and one month after the intervention. Method of measurement: Patients will be evaluated by Beck Depression Scale.;Symptoms of Anxiety. Timepoint: Patients will be evaluated before the intervention, after the end of the intervention session and one month after the intervention. Method of measurement: Patients will be evaluated by Beck Anxiety Scale.;Quality of Life. Timepoint: Patients will be evaluated before the intervention, after the end of the intervention session and one month after the intervention. Method of measurement: Patients will be evaluated by SF36.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAida Yahyazadeh

Rasht University of Medical Sciences

aidayahyazadeh@yahoo.com+98 13 3366 6268

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026